Room temperature stable carbetocin versus oxytocin for prevention of postpartum haemorrhage after vaginal birth

Phase 3, randomised trial of carbetocin and oxytocin in postpartum hemorrhage (PPH), sponsored by World Health Organization. Primary endpoints: Composite primary outcome: blood loss of 500 mL or more or use of additional uterotonics and Blood loss of 1000 mL or more. Started Jul 2015; status: completed.